PARENTERAL VIRAL HEPATITIS B, C AND G IN PATIENTS WITH HIV-INFECTION (LITERATURE REVIEW)
Abstract
The current review presents background information on influence of viral hepatitis B, C and D on the course of HIV-infection according to the latest worldwide and nationwide molecular epidemiological studies.
About the Authors
E. A. Bazykina
Federal Budget Institution of Science “Khabarovsk research institute of epidemiology and microbiology” of the Federal service for surveillance on customer rights protection and human well being (Rospotrebnadzor)
Russian Federation
Russian Federation
O. E. Trotsenko
Federal Budget Institution of Science “Khabarovsk research institute of epidemiology and microbiology” of the Federal service for surveillance on customer rights protection and human well being (Rospotrebnadzor)
Russian Federation
Russian Federation
V. O. Kotova
Federal Budget Institution of Science “Khabarovsk research institute of epidemiology and microbiology” of the Federal service for surveillance on customer rights protection and human well being (Rospotrebnadzor)
Russian Federation
Russian Federation
L. A. Balakhontseva
Federal Budget Institution of Science “Khabarovsk research institute of epidemiology and microbiology” of the Federal service for surveillance on customer rights protection and human well being (Rospotrebnadzor)
Russian Federation
Russian Federation
V. B. Turkutyukov
Federal State Budget Educational Institution of Higher Education “Pacific State Medical University” of the Ministry of Public Health of Russian Federation”
Russian Federation
Russian Federation
References
1. Азовцева О.В., Архипова Е.И., Архипов Г.С. Клинико-генотипическая характеристика коинфекции вирусного гепатита С и ВИЧ // ВИЧ-инфекция и иммуносупрессия - 2010. - Том 2., № 2 - С 42-47.
2. Бегайдарова Р.Х., Стариков Ю.Г., Алшынбекова Г.К. и др. Ко-инфекция ВИЧ/ВГС у пациентов азиатской национальности по Казахстану // Международный журнал прикладных и фундаментальных исследований. - №1. 2016. - с. 339-342
3. Быстрова Т. Н., Корочкина О. В., Михайлова Ю. В., Карувваккат О. С. Генотипическое разнообразие вируса гепатита С, циркулирующего среди населения Нижегородской области // Медицинский альманах. - 2011. - №4. - с. 32-34.
4. Богач В.В. ВИЧ-инфекция и вирусные гепатиты на Дальнем Востоке России. - Хабаровск 1998г. - 372 с.
5. Демиденко Т.П., Неверов В.А. Вирусные гепатиты: Пособие для врачей /; Под ред. Ю.В. Лобзина - СПб., 2011. -229 с.
6. Ивашкин В.Т., Ющук Н.Д., Маевская М.В., и др. Клинические рекомендации Российской гастроэнтерологической ассоциации и Российского общества по изучению печени по диагностике и лечению взрослых больных гепатитом В. Росс. Журн. гастроэнтерол. гепатол колопроктол.- 2014. - Т.24. - №3. - С.58-88.
7. Иоанниди Е.А., Чернявская О.А., Горшкова Н.В. Хронические вирусные гепатиты и ВИЧ-инфекция: Учебное пособие- Волгоград: Изд-во ВолГМУ, 2008. - 51с.
8. Кожанова Т.В. Первичная лекарственная резистентность вируса гепатита В: Автореф. дис.. канд. мед. наук : 03.02.02. / - Москва, 2010. - 23 с.
9. Кочнева Г.В., Мануйлов В.А., Нетесова И.Г., и др. Генотипы и субтипы изолятов вируса гепатита В на территории Сибири, // Проблемы особо опасных инфекций. - 2011 - № 3(109), стр. 31 - 35.
10. Кругляк С. П., Махно Е. С., Самойлова Н. Ф. Распространение генотипов вируса гепатита C в Приморском крае // Тихоокеанский мед. журн. - 2009. - №4 (38). - с. 39-40.URL: http://cyberleninka.ru/article/n/rasprostranenie-genotipov-virusa-gepatita-s-v-primorskom-krae (дата обращения: 12.09.2016).
11. Лаптева Н. И. Интеграционная эпидемиология инфекций с гемоконтактным механизмом передачи (ВИЧ, гепатиты B и C) в Республике Саха (Якутия): автореферат дис.. кандидата медицинских наук : 14.02.02 / Лаптева Ньургустана Ивановна; [Место защиты: Ом. гос. мед. акад.]. - Омск, 2014. - 22 с.
12. Майер К.-П. Гепатит и последствия гепатита. - Москва: ГЭОТАР-Мед, 2004. - 717 с.
13. Максимов С.Л., Царенко С.П., Кравченко А.В., Ганкина Н.Ю., Ющук Н.Д. Маркёры хронического гепатита В у больных ВИЧ-инфекцией и подходы к терапии. // Росс. Журн. Гастроэнтерол., Гепатол., Колопроктол. - 2010. - № 5. - С. 22-26.
14. Медведева Т.В., Некипелов О.М., Никитина Е.Г., Скворцова Р.Г. О необходимость обязательного исследования образцов крови на присутствие ВИЧ, положительных по отношению к гепатиту С.
15. // Сибирский мед. журн. 2010. № 6. с. 187-188
16. Михайлов М.И., К.К. Кюрегян. Молекулярно-биологические основы контроля вирусных гепатитов. - М.: Изд. Икар, 2013. - 336 с.: ил.
17. Скляр Л. Ф., Ли Ю. А., Горелова И. С. Противовирусная терапия парентеральных гепатитов у ВИЧ-инфицированных пациентов в Приморском крае // Тихоокеанский мед. журн. - 2009. - №4 (38). - с. 80-82. URL: http://cyberleninka.ru/article/n/protivovirusnaya-terapiya-parenteralnyh-gepatitov-u-vich-2infitsirovannyh-patsientov-v-primorskom-krae (дата обращения: 12.09.2016)
18. Слепцов А. П. Вирусный гепатит в Якутии. // Сибирский мед. журн. - 2007. - №2. - с. 52-54. URL: http://cyberleninka.ru/article/n/virusnyy-gepatit-v-yakutii (дата обращения: 12.09.2016).
19. Старостина И.С., Троценко О.Е., Иванов А.Н., и др. Парентеральные вирусные гепатиты и состояние функции печени у ВИЧ-инфицированных из учреждений пенитенциарной системы.: Библ. инфекц. патолог. Выпуск 29. - Хабаровск 2009, 209 с.
20. Троценко О.E. ВИЧ-инфекция/СПИД в Дальневосточном федеральном округе Российской Федерации: Эпидемиологическая характеристика: Автореф. дис. … д-ра мед. наук: - М., 2005. - 47 с.
21. Хоронжевская И.С., Мартынюк Г.А., Шевченко Г.Н., и др. Изучение структуры генотипов вируса гепатита С на территории Ровенской области северо-западной части Украины // Инфекция и иммунитет. - 2012. - №1-2. - с. 463-464.
22. Aghasadeghi M.R., Mohraz M., Bahramali G., et al. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis // Hepat Mon. - 2013 May. - 13(5). - P. 1-5. - e7481.
23. Alberti A., Lacoin L., Morais E., et al. Literature review of the distribution of hepatitis C virus genotypes across Europe. J Med Virol. 2016 May 12. doi: 10.1002/jmv.24573. [Epub ahead of print]
24. Alexiev I., Shankar A., Dimitrova R. et al. Origin and spread of HIV-1 in persons who inject drugs in Bulgaria. // Infect Genet Evol. - 2016. pii: S1567-1348(16)30201-5. doi: 10.1016/j.meegid.2016.05.029. [Epub ahead of print]
25. Anggorowati N., Yano Y., Heriyanto D.S., et al. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients. // J Med Virol. - 2012 - Vol. 84 - № 6 - P. 857-65.
26. Alvarado-Mora M.V., Locarnini S.,Rizzetto M., Pinho J.R. An update on HDV: virology, pathogenesis and treatment. // Antivir Ther. - 2013 - Vol. 18(3 Pt B) - P.541-8. doi: 10.3851/IMP2598. Epub 2013 Jun 21.
27. Antonello V.S., Antonello I.C., Zaltron R.F., Tovo C.V. HIV and hepatitis C virus coinfection. Who is the patient today? // Arq Gastroenterol. 2016 Jul-Sep -Vol. 53(3) - P. 180-4. doi: 10.1590/S0004-28032016000300011.
28. Arıkan A., Şanlıdağ T., Süer K., et al. Molecular epidemiology of hepatitis B virus in Northern Cyprus. Mikrobiyol Bul. 2016 Jan. - Vol. 50(1). - P. 86-93.
29. Baudi I., Iijima S., Chin'ombe N., et al. Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe // J Med Virol. - 2016 Jul 26. doi: 10.1002/jmv.24641. [Epub ahead of print]
30. Bautista-Amorocho H., Castellanos-Domínguez Y.Z., Rodríguez-Villamizar L.A. et. al. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance. // PLoS One. - 2014. - Vol. 9, №12. - P. 1-14.
31. Béguelin C., Moradpour D., Sahli R., et all. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients // Kaohsiung J Med Sci. - 2016 Oct. - Vol. 32(10). - P. 526-530. doi: 10.1016/j.kjms.2016.08.004. Epub 2016 Sep 18.
32. Brandão N.A., Pfrimer I.A., Martelli C.M., Turchi M.D. Prevalence of hepatitis B and C infection and associated factors in people living with HIV in Midwestern Brazil. // Braz J Infect Dis. - 2015. Vol. 19, № 4. - P. 426-30.
33. Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, et al. Factors that predict response of patients with hepatitis B e antigen- positive chronic hepatitis B to peginterferon-alfa // Gastroenterology 2009. - Vol. 137. -P. 2002-9.
34. Carobene M., Bolcic F., Farías M.S., et al. HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina. // J Med Virol. - 2014. - Vol. 86, № 1. - P. 64-70.
35. Delwart E., Slikas E., Stramer S.L., et al. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. // J Infect Dis. - 2012. - Vol. 205, № 6 - P. 875-85.
36. de Vera M.E., Dvorchik I., Tom K. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C // Am J Transplant. - 2006 Dec. -Vol. 6(12). - P. 2983-93.
37. de Villiers E.-M., Borkosky S.S. , Kimmel R., Gunst K., and Fei J.-W. The Diversity of Torque Teno Viruses: In Vitro Replication Leads to the Formation of Additional Replication-Competent Subviral Molecules. J Virol. 2011 Jul; 85(14): 7284-7295. doi: 10.1128/JVI.02472-10
38. di Filippo Villa D., Cortes-Mancera F., Payares E., et al. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia // Virol J. - 2015 Oct 2. - Vol. 24, № 12. -P.172. doi: 10.1186/s12985-015-0402-5.
39. Diop-Ndiaye H., Touré-Kane C., Etard J.F., et al. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study) // J Med Virol. - 2008 Aug. - Vol. 80(8). -P. 1332-6. doi: 10.1002/jmv.21236.
40. Dong Y., Qiu C., Xia X., et al. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. // Arch Virol. - 2015 - Vol.160 - № 4 - P. 929-936.
41. Fernández-Montero J.V., Vispo E., Barreiro P., et al. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients // Clin Infect Dis. - 2014 Jun. - Vol. 58(11). - P. 1625-33. doi: 10.1093/cid/ciu127. Epub 2014 Mar 5.
42. Gatserelia L., Sharvadze L., Karchava M., Dolmazashvili E., Tsertsvadze T. Occurrence of occult HCV infection among HIV infected patients in Georgia // Georgian Med News. - 2014 Jan. - Vol. 226. - P. 37-41.
43. Gitau S.N., Vinayak S., Silaba M., Adam R., Shah R. et all. High Prevalence of Liver Fibrosis in Patients with Human Immunodeficiency Virus Monoinfection and Human Immunodeficiency Virus Hepatitis-B Co-infection as Assessed by Shear Wave Elastography: Study at a Teaching Hospital in Kenya // J Clin Imaging Sci. - 2016. Vol. 6. - P. 22. Published online 2016 Jun 7. doi: 10.4103/2156-7514.183582
44. Gjærde L.I., Shepherd L., Jablonowska E., et all. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study // Clin Infect Dis. - 2016 Sep 15. - Vol. 63(6). - P. 821-9. doi: 10.1093/cid/ciw380. Epub 2016 Jun 15.
45. Guimarães Nebenzahl H., Lopes A., Castro R., Pereira F. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. // S Afr Med J. - 2013. - Vol. 103. - № 3. - P. 186-188.
46. Gupta S., Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients // World J Gastroenterol. - 2006 Nov 14. - Vol. 12(42). - P. 6879-83.
47. He Y., Zhao Q.X., Ren Y.J., Ding L.M. Coinfection with HBV and HCV in 128 AIDS patients infected through blood transmission // Zhongguo Yi Xue Ke Xue Yuan Xue Bao. - 2006 Oct. - Vol. 28(5). -P. 662-4.
48. Hsieh M.H., Wang S.C., Hsieh M.Y., et al. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan // Kaohsiung J Med Sci. - 2016 Oct. -Vol. 32(10). - P. 526-530. doi: 10.1016/j.kjms.2016.08.004. Epub 2016 Sep 18.
49. Jacka B., Applegate T., Poon A.F., Raghwani J., Harrigan P.R. Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada // J Hepatol. 2016 Jun. Vol. 64(6). P. 1247-55. doi: 10.1016/j.jhep.2016.02.031. Epub 2016 Feb 26.
50. Ju W., Yang S., Feng S., et al. Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6 // Virol J. - 2015 Jul 25. Vol. 12. P. 109. doi: 10.1186/s12985-015-0341-1
51. Kay A., Melo da Silva E., Pedreira H., et al. HBV/HDV co-infection in the Western Brazilian Amazonia: an intriguing mutation among HDV genotype 3 carriers // J Viral Hepat. - 2014 Dec. Vol. 21(12). P. 921-4. doi: 10.1111/jvh.12267. Epub 2014 Jul 9.
52. Klein M.B., Althoff K.N., Jing Y. et all. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras // Clin Infect Dis. - 2016 Aug 9. pii: ciw531. [Epub ahead of print]
53. Lee C.Y., Tsai H.C., Lee S.S., et al. Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan. J Microbiol Immunol Infect. // 2015 Feb. - Vol. 48(1). P. 20-7. doi: 10.1016/j.jmii.2013.08.001. Epub 2013 Sep 21.
54. Li J.R., Gong R.Y., Tian K.L., et al. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users // World J Gastroenterol. - 2007 Apr 28. Vol. 13(16). - P. 2357-62.
55. Lin H.H., Lee S.S., Yu M.L., et al. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program // Hepatology. - 2015 Jun. - Vol. 61(6). P. 1870-9. doi: 10.1002/hep.27742. Epub 2015 Apr 20.
56. Lin S.Y., Toyoda H., Kumada T., Liu H.F. Molecular Evolution and Phylodynamics of.Acute Hepatitis B Virus in Japan // PLoS One. - 2016 Jun 9. - Vol. 11(6):e0157103. doi: 10.1371/journal.pone.0157103. eCollection 2016.
57. Liweń I., Januszkiewicz-Lewandowska D., Nowak J. TT virus-characteristics, occurrence and routes of transmission // Przegl Epidemiol. - 2002. Vol. 56(1). P. 91-9.28. doi: 10.3748/wjg.v12.i32.5122 PMCID: PMC4088008
58. Maaref F., Kilani B., Ammari L., et al. Prevalence of hepatitis G, B and C virus infections among positive HIV population in a Tunisian Hospital, La Rabta, Tunis. // Pathol Biol (Paris). - 2011. - Vol. 59. - № 4. - P.213-216.
59. Mello F.C., Araujo O.C., Lago B.V., et al. Phylogeography and evolutionary history of hepatitis B virus genotype F in Brazil // Virol J. - 2013 Jul 16. Vol. 10. - P. 236. doi: 10.1186/1743-422X-10-236.
60. Mojsiejczuk L.N., Torres C., Sevic I., et al. Molecular epidemiology of hepatitis B virus in Misiones, Argentina // Infect Genet Evol. - 2016 Jun 16. -P. 34-42. doi: 10.1016/j.meegid.2016.06.032. [Epub ahead of print]
61. Motamedifar M., Taheri M., Lankarani K.B., et al, Sarvari J. The Prevalence and Risk Factors of Hepatitis Delta Virus in HIV/HBV Co-Infected Patients in Shiraz, Iran, 2012 // Iran J Med Sci. - 2015 Sep. Vol. 40(5). P. - 448-53.
62. Peters L., Klein M.B. Epidemiology of hepatitis C virus in HIV-infected patients // Curr Opin HIV AIDS. - 2015 Sep. Vol. 10(5). P. 297-302. doi: 10.1097/COH.0000000000000183.
63. Peters P.J., Pontones P., Hoover K.W., et all. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015 // N Engl J Med. - 2016 Jul 21. - Vol. 375(3). P. 229-39. doi: 10.1056/NEJMoa1515195.
64. Pinchoff J., Tran O.C., Chen L., et al. Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011 // Epidemiol Infect. - 2016 Aug.- Vol. 11. P. 1-11. [Epub ahead of print]
65. Piroth L., Carrat F., Larrat S., et al. Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy // J Hepatol. - 2008 Dec. - Vol. 49(6). - P. 892-8. doi: 10.1016/j.jhep.2008.06.024. Epub 2008 Jul 17.
66. Piroth L., Pol S., Lacombe K., et al. Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study // J Hepatol. - 2010 Dec. - Vol. 53(6). P. 1006-12. doi: 10.1016/j.jhep.2010.04.041. Epub 2010 Aug 4.
67. Platt L., Easterbrook P., Gower E. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta- analysis // Lancet Infect Dis. - 2016 Jul. Vol. 16(7). P. 797-808. doi: 10.1016/S1473-3099(15)00485-5. Epub 2016 Feb 25.
68. Pourkarim M.R., Amini-Bavil-Olyaee S., Kurbanov F., Van Ranst M., Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions // World J Gastroenterol. - 2014 Jun 21. - Vol. 20(23). P. 7152-68. doi: 10.3748/wjg.v20.i23.7152.
69. Prasetyo A.A., Dirgahayu P., Sari Y., et al. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia. // J Infect Dev Ctries. - 2013. - Vol. 7, № 6. - P. 453-467.
70. Prussing C., Chan C., Pinchoff J., et al, Fuld J. HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics // Epidemiol Infect. - 2015 May. - Vol. 143(7). P. 1408-16. doi: 10.1017/S0950268814002209. Epub 2014 Aug 29.
71. Ramos B., Núñez M., Toro C., Sheldon J, García-Samaniego J., Ríos P., Soriano V. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients // J Infect. - 2007 Feb. Vol. 54(2). P. 173-9. Epub 2006 Mar 29.
72. Sadeghi A., Shirvani-Dastgerdi E., Tacke F. HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg // J Med Virol. - 2016 Jul 6. doi: 10.1002/jmv.24623. [Epub ahead of print]
73. Sadeghi F., Salehi-Vaziri M., Almasi-Hashiani A., et al. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis // Hepat Mon. - 2016 Apr 19. - Vol. 16(4):e35558. doi: 10.5812/hepatmon.35558. eCollection 2016.
74. Sarkar J. , Saha D., Bandyopadhyay B. Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India // Indian J Med Res. - 2016 May. - Vol. 143(5). P. 636-42. doi: 10.4103/0971-5916.187113.
75. Sherman K. E., Thomas D., Chung R.T. Human Immunodeficiency Virus and Liver Disease Forum 2012 // Hepatology. - 2014 January. Vol. 59(1). -doi:10.1002/hep.26638
76. Soriano V., Barreiro P., Sherman K.E. The Changing Epidemiology of Liver Disease in HIV Patients // AIDS Rev. - 2013. - Vol. 15. P. 25-31.
77. Soriano V., Grint D., d'Arminio Monforte A., et al. Hepatitis delta in HIV-infected individuals in Europe // AIDS. - 2011 Oct 23. - Vol. 25(16). - P. 1987-92.doi:10.1097/QAD.0b013e32834babb3.
78. Spandole S., Cimponeriu D., Berca L.M., Mihăescu G. Human anelloviruses: an update of molecular, epidemiological and clinical aspects // Arch Virol. 2015 Apr. Vol. 160(4). P. 893-908. doi: 10.1007/s00705-015-2363-9. Epub 2015 Feb 15.
79. Sunbul M. Hepatitis B virus genotypes: Global distribution and clinical importance // World Journal of Gastroenterology. - 2014. - Vol. 20(18).P. 5427-5434. doi:10.3748/wjg.v20.i18.5427.
80. Thio C.L., Smeaton L., Saulynas M., et al. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort // AIDS. - 2013 Jan 14. - Vol. 27(2). P. 191-201. doi: 10.1097/QAD.0b013e32835a9984
81. Urwijitaroon Y., Barusrux S., Chunlertlith K., Mairiang P., Yoshimura H. Torquetenovirus infection among northeastern Thai blood donors // Southeast Asian J Trop Med Public Health. - 2007 Jul. Vol. 38(4). - P. 686-9.
82. Vinikoor M.J., Mulenga L., Siyunda A. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia // Trop Med Int Health. - 2016 Aug 6. doi: 10.1111/tmi.12764. [Epub ahead of print]
83. Winter A., Letang E., Vedastus Kalinjuma A., et al. Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania // Int J Infect Dis. - 2016 May. - Vol. 46. - P. 8-10. doi: 10.1016/j.ijid.2016.03.011. Epub 2016 Mar 17.
84. Wu S., Yan P., Yang T., Wang Z., Yan Y. Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China // J Med Virol. - 2016 Aug 23. doi: 10.1002/jmv.24666. [Epub ahead of print]
85. Xie Y., Garza G., Dong J. Hepatitis C Virus Genotype and Subtype Distribution in Patient Specimens Tested at the University of Texas Medical Branch, Galveston, Between January 2011 and November 2014 // Lab Med. - 2016 May. Vol. 47(2). - P. 112-8. doi: 10.1093/labmed/lmw004. Epub 2016 Mar 19
86. Zhang Q., Liao Y., Chen J., et al. Epidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from Western China // Sci Rep. - 2015 Nov 27. - Vol. 5. - P. 17413. doi: 10.1038/srep17413.
Review
For citations:
Bazykina E.A., Trotsenko O.E., Kotova V.O., Balakhontseva L.A., Turkutyukov V.B. PARENTERAL VIRAL HEPATITIS B, C AND G IN PATIENTS WITH HIV-INFECTION (LITERATURE REVIEW). Far Eastern Journal of Infectious Pathology. 2016;(31):38-47. (In Russ.)
Views:
508
Email this article 